Clinical Trial Update: Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating demeclocycline-induced fluorescence for intraoperative delineation of brain tumors; trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Demeclocycline (demeclocycline)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Brain Tumor | Phase 1 | Status: UNKNOWN